Differential effect of genistein on transforming growth factor β1 expression in normal and malignant mammary epithelial cells

Anticancer Research

Volumn 18, Issue 4 A, 1998, Pages 2449-2453

  Sathyamoorthy, Neeraja ^a   Gilsdorf, Janice S ^a   Wang, Thomas T Y ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Genistein; MCF 7 and human mammary epithelial cells; TGF 1 mRNA

Indexed keywords

GENISTEIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER INHIBITION; CELL STRAIN MCF 7; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; BREAST; BREAST NEOPLASMS; CELL DIVISION; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; KINETICS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0031839332     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Peterson G and Barnes S: Genistein and Biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 22: 335-345, 1993.
2. Peterson G and Barnes S: Genistein inhibits both estrogen and growth factor stimulated proliferation of human breast cancer cells. Cell Growth Differ 7: 1345-1351, 1996.
3. Wang TTY, Sathyamoorthy N and Phang JM: Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17: 271-275, 1996.
4. Murrill WB, Brown NM, Zhang JX, Manzolillo PA, Barnes S and Lamartiniere CA: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation of rats. Carcinogenesis 17: 1451-1457, 1996.
5. Lamartiniere CA, Moore J, Holland M and Barnes S: Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 208: 120-123, 1995.
6. Perry RR, Kang Y and Greaves BR. Relationship between tamoxifen-induced transforming growth factor ß1 expression, cytostasis and apoptosis in human breast cancer cells. Br J Cancer 72: 1441-1446, 1995.
7. Colletta AA, Wakefield LM, Howell FV, van Roozendaal KEP, Danielpour D, Ebbs SR, Sporn MB and Baum M: Antiestrogens induce the secretion of active transforming growth factor ß from human fetal fibroblasts. Br J Cancer 62: 3040-3045, 1990.
8. Roberts AB and Sporn MB: Peptide growth factors and their receptors, Part I (Sporn MB and Roberts AB eds). Springer-Verlag, Berlin, 1990, pp. 421-472.
9. Massague J: The transforming growth factor ß family Ann Rev Cell Biol 6: 597-641, 1990.
10. Moses HL, Yang EY and Pietenpol JA: TGF ß stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63: 245-257, 1990.
11. Alexandrow MG and Moses HL: Transforming growth factor and cell cycle regulation. Cancer Res 55: 1452-1457, 1995.
12. Wakefield LM, Colletta AA, McCune BK, and Sporn MB: Genes, Oncogenes and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer. (Dickson RB and Lippman ME eds.). Kluwer Academic Publishers, Boston, 1991 pp. 98-136.
13. Sathyamoorthy N, Wang TTY, and Phang JM: Stimulation of pS2 expression by diet-derived compounds. Cancer Res 54: 957-961, 1994.
14. Temin HM: Carcinogenesis by avian sarcoma viruses. Int J Cancer 3: 771-787, 1968.
15. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112, 1990.
16. Peterson TG, Coward KM, Falany CN, and Barnes S: The role of metabolism in mammary epithelial cell growth inhibtion by the isoflavones genistein and biochanin A. Carcinogenesis 17: 1861-1869, 1996.
17. Koli K and Keski-Oja-J: 1, 25 dihydroxyvitamin D3 enhances the expression of transforming growth factor ß1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res 55: 1540-1546, 1995.
18. Scambia G, Benedetti Panici P, Ranelletti F, Ferrandina G, De Vincenzo R, Piantelli M, Masciullo V, Bonanno G, Isola G and Mancuso S: Quercetin enhances transforming growth factor ß1 secretion by human ovarian cancer cells. Int J Cancer 57: 211-215, 1994.
19. Dickens TA and Colletta AA: The pharmacological manipulation of members of the transforming growth factor ß family in the chemoprevention of breast cancer. Bioessays 15: 71-74, 1993.
20. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J and Day NE: Dietary effects on breast cancer risk in Singapore. Lancet 337: 1197-1200, 1991.
21. Adlercreutz H, Honjo H, Higashi et al: Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 54: 1093-1100, 1991.
22. Murrill WB, Brown NM, Zhang JX, Manzolillo PA, Barnes S and Lamartiniere CA: Prepubertal gensitein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17: 1451-1457, 1996.
23. Adlercreutz H Markkanen H and Watanabe S: Plasma concentration of phytoestrogens in Japanese men. Lancet 342: 1209-1210, 1993.
24. Xu, X, Xang HJ Murphy PA Cook L and Hendrich S: Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124: 825-832, 1994.